GSK, Pfizer and Sanofi escape US federal litigation over Zantac
While the companies, which have all marketed the drug at different times, still face tens of thousands of similar lawsuits in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GSK
GSK to stop selling blood cancer drug Blenrep in US
The company had said this month that Blenrep had failed the main goal of a key study designed to show it was better than an…
GSK to bounce regulatory submissions for experimental arthritis drug
In a late-stage study, the antibody-based drug, otilimab, did not make a meaningful difference to improving swelling and…
Shingrix can provide at least 10 years of protection against shingles in adults aged 50 years and…
GSK plans to bring Shingrix to India in 2023
GSK says key trial data shows its RSV vaccine is ‘truly exceptional’
The trial, which involved roughly 25,000 adults aged 60 years and more, tested a single dose of the experimental vaccine against a…
Haleon rejects Zantac indemnification requests from GSK and Pfizer
Zantac, originally marketed by a forerunner of GSK, has been sold by several companies at different times, including Pfizer,…
WHO grants prequalification to GSK’s malaria vaccine
Working in collaboration with PATH and other partners, GSK developed Mosquirix, the first vaccine to help protect children against…
US FDA accepts New Drug Application for GSK’s momelotinib for treatment of myelofibrosis
Regulatory submission included data from the pivotal Momentum phase-III clinical trial that met all primary and key secondary…
GSK, IQVIA launch Vaccine Track, a data trend platform to improve adult vaccination in US
Vaccine Track data insights revealed sustained decline of recommended adult immunisations, excluding flu vaccinations, across the…
GSK gets US FDA nod for Benlysta (Belimumab) to treat paediatric patients with active lupus…
Benlysta is now the first and only biologic approved for adults and children who have lupus or lupus nephritis